Search Results for “” – Page 7 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Change patient management Observational

236 Publications found

Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial.

b

Journal of Crohn's & colitis

February 23, 2022

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary.

b

The oncologist

February 3, 2022

p Cancer

c Change patient management Clinical outcomes Observational
Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies.

b

Clinical cardiology

February 1, 2022

p Cardiovascular Disease

c Change patient management Clinical outcomes Meta-analysis Observational Review
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

b

BMC medicine

February 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational Safety
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

b

Cancer discovery

February 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?

b

Inflammatory intestinal diseases

January 1, 2022

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Observational Operational efficiencies Patient-centeredness
The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.

b

Frontiers in genetics

January 1, 2022

p Newborn Screening

c Change patient management Clinical outcomes Observational
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program.

b

Translational oncology

January 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational
Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine.

b

JCO precision oncology

January 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational
Multi-omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.

b

Molecular oncology

January 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational